BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12491208)

  • 21. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe pruritus after completing pegylated interferon for hepatitis C.
    Hoffman CJ; Ray SC
    AIDS Read; 2008 Nov; 18(11):562-5. PubMed ID: 19062400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical management of HIV/hepatitis C virus coinfection.
    Pozza R
    J Am Acad Nurse Pract; 2008 Oct; 20(10):496-505. PubMed ID: 19128345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of HIV-HCV and HBV-HCV co-infection].
    Jmelnitzky AC; Jorge O; Manero E
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection.
    Adeyemi OM; Jensen D; Attar B; Ghaoui R; Gallagher M; Wolen D; Cotler SJ
    AIDS Patient Care STDS; 2004 Apr; 18(4):239-45. PubMed ID: 15142354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.
    Mocroft A; Rockstroh J; Soriano V; Kirk O; Viard JP; Caplinskas S; Gasiorowski J; Chiesi A; Phillips AN; Lundgren JD;
    Scand J Infect Dis; 2006; 38(11-12):1092-7. PubMed ID: 17148084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C treatment eligibility among HIV-hepatitis C virus coinfected patients in Oregon: a population-based sample.
    Maier MM; He H; Schafer SD; Ward TT; Zaman A
    AIDS Care; 2014; 26(9):1178-85. PubMed ID: 24601687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coinfection of hepatitis C virus and human immunodeficiency virus and antiretroviral multitherapies].
    Zylberberg H; Pol S
    Gastroenterol Clin Biol; 1999; 23(8-9):878-81. PubMed ID: 10533139
    [No Abstract]   [Full Text] [Related]  

  • 30. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 31. [Coinfection by human immunodeficiency virus and hepatitis C virus].
    Lana Soto R; Mendoza Hernández JL; Lérida Urteaga AI; Alvarez-Sala Walther JL
    Rev Clin Esp; 1998 Apr; 198(4):237-41. PubMed ID: 9633210
    [No Abstract]   [Full Text] [Related]  

  • 32. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 33. Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C.
    Krämer B; Nischalke HD; Boesecke C; Ingiliz P; Voigt E; Mauss S; Stellbrink HJ; Baumgarten A; Rockstroh JK; Spengler U; Nattermann J
    AIDS; 2013 Nov; 27(17):2817-9. PubMed ID: 23939236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

  • 35. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.
    Kim AY; Chung RT; Polsky B
    AIDS Clin Rev; 2000-2001; ():263-306. PubMed ID: 10999223
    [No Abstract]   [Full Text] [Related]  

  • 36. Understudied populations with hepatitis C.
    Strader DB
    Hepatology; 2002 Nov; 36(5 Suppl 1):S226-36. PubMed ID: 12407598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating hepatitis C: a clinician's perspective. Interview by Bob Roehr.
    Powell J
    J Int Assoc Physicians AIDS Care; 1998 Jul; 4(7):31-5. PubMed ID: 11365640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management issues in patients coinfected with hepatitis C virus and HIV.
    Bonacini M
    AIDS Read; 2002 Jan; 12(1):19-21, 24-6. PubMed ID: 11862656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivering care to injection drug users coinfected with HIV and hepatitis C virus.
    Taylor LE
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S355-61. PubMed ID: 15768348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hepatitis C virus and HIV co-infections.
    Cotler SJ; Jensen DM
    Clin Liver Dis; 2001 Nov; 5(4):1045-61. PubMed ID: 11685794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.